Tag Archives: Invokana

New Drug for Type 2 Diabetes Approved by the FDA

The U.S. Food and Drug Administration recently approved Johnson & Johnson’s first of a new class of anti-diabetes drugs, called Invokana, to treat type 2 diabetes. Type 2 diabetes affects about 24 million people and accounts for more than 90 … Continue reading

Posted in Diabetes Day2Day | Tagged , , | 4 Comments